BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9064880)

  • 1. [The natural course of untreated, localized primary prostate carcinoma].
    Johansson JE
    Urologe A; 1996 Nov; 35(6):446-8. PubMed ID: 9064880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Natural disease course in untreated early prostatic carcinoma--the Orebro Study].
    Johansson JE
    Praxis (Bern 1994); 2001 Sep; 90(36):1507-14. PubMed ID: 11593906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of localised prostatic cancer. A population-based study in 223 untreated patients.
    Johansson JE; Adami HO; Andersson SO; Bergström R; Krusemo UB; Kraaz W
    Lancet; 1989 Apr; 1(8642):799-803. PubMed ID: 2564901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expectant management of early stage prostatic cancer: Swedish experience.
    Johansson JE
    J Urol; 1994 Nov; 152(5 Pt 2):1753-6. PubMed ID: 7933233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of early, localized prostate cancer: a final report from three decades of follow-up.
    Popiolek M; Rider JR; Andrén O; Andersson SO; Holmberg L; Adami HO; Johansson JE
    Eur Urol; 2013 Mar; 63(3):428-35. PubMed ID: 23084329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Delayed therapy of clinically localized prostatic carcinoma. Experiences of the Karolinska Hospital].
    Adolfsson J
    Urologe A; 1996 Nov; 35(6):454-5. PubMed ID: 9064882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden.
    Johansson JE; Holmberg L; Johansson S; Bergström R; Adami HO
    JAMA; 1997 Feb; 277(6):467-71. PubMed ID: 9020270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High 10-year survival rate in patients with early, untreated prostatic cancer.
    Johansson JE; Adami HO; Andersson SO; Bergström R; Holmberg L; Krusemo UB
    JAMA; 1992 Apr 22-29; 267(16):2191-6. PubMed ID: 1556796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival in a Swedish population-based cohort of men with prostate cancer.
    Sandblom G; Dufmats M; Varenhorst E
    Urology; 2000 Sep; 56(3):442-7. PubMed ID: 10962312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of early, localized prostate cancer.
    Johansson JE; Andrén O; Andersson SO; Dickman PW; Holmberg L; Magnuson A; Adami HO
    JAMA; 2004 Jun; 291(22):2713-9. PubMed ID: 15187052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of prostate carcinoma based on a Danish population treated with no intent to cure.
    Borre M; Nerstrøm B; Overgaard J
    Cancer; 1997 Sep; 80(5):917-28. PubMed ID: 9307192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of prostate carcinoma death in patients with lymph node metastasis.
    Cheng L; Zincke H; Blute ML; Bergstralh EJ; Scherer B; Bostwick DG
    Cancer; 2001 Jan; 91(1):66-73. PubMed ID: 11148561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-curative treatment of prostate carcinoma. Outcome in Göteborg].
    Aus G; Hugosson J
    Urologe A; 1996 Nov; 35(6):449-53. PubMed ID: 9064881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mortality due to prostatic carcinoma in northern Sweden].
    Damber JE; Grönberg H
    Urologe A; 1996 Nov; 35(6):443-5. PubMed ID: 9064879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer mortality in northern Sweden, with special reference to tumor grade and patient age.
    Grönberg H; Damber L; Jonson H; Damber JE
    Urology; 1997 Mar; 49(3):374-8. PubMed ID: 9123701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
    Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
    Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden.
    Aus G; Robinson D; Rosell J; Sandblom G; Varenhorst E;
    Cancer; 2005 Mar; 103(5):943-51. PubMed ID: 15651057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential benefit of improved local tumor control in patients with prostate carcinoma.
    Kuban DA; el-Mahdi AM; Schellhammer PF
    Cancer; 1995 May; 75(9):2373-82. PubMed ID: 7536125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
    Kishan AU; Cook RR; Ciezki JP; Ross AE; Pomerantz MM; Nguyen PL; Shaikh T; Tran PT; Sandler KA; Stock RG; Merrick GS; Demanes DJ; Spratt DE; Abu-Isa EI; Wedde TB; Lilleby W; Krauss DJ; Shaw GK; Alam R; Reddy CA; Stephenson AJ; Klein EA; Song DY; Tosoian JJ; Hegde JV; Yoo SM; Fiano R; D'Amico AV; Nickols NG; Aronson WJ; Sadeghi A; Greco S; Deville C; McNutt T; DeWeese TL; Reiter RE; Said JW; Steinberg ML; Horwitz EM; Kupelian PA; King CR
    JAMA; 2018 Mar; 319(9):896-905. PubMed ID: 29509865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.